Comorbidity Scores and Machine Learning Methods Can Improve Risk Assessment in Radical Cystectomy for Bladder Cancer

Overview

Journal Bladder Cancer

Publisher IOS Press

Date 2024 Jul 12

PMID 38993365

Authors

Frederik Wessels

Isabelle Bussoff

Sophia Adam

Karl-Friedrich Kowalewski

Manuel Neuberger

Philipp Nuhn

Maurice S Michel

Maximilian C Kriegmair

Affiliations

Soon will be listed here.

Abstract

Background: Pre-operative risk assessment in radical cystectomy (RC) is an ongoing challenge especially in elderly patients.

Objective: To evaluate the ability of comorbidity indices and their combination with clinical parameters in machine learning models to predict mortality and morbidity after RC.

Methods: In 392 patients who underwent open RC, complication and mortality rates were reported. The predictive values of the age-adjusted Charlson Comorbidity index (aCCI), the Elixhauser Index (EI), the Physical Status Classification System (ASA) and Gagne's combined comorbidity Index (GCI) were evaluated using regression analyses. Various machine learning models (Gaussian naïve bayes, logistic regression, neural net, decision tree, random forest) were additionally investigated.

Results: The aCCI, ASA and GCI showed significant results for the prediction of complications (χ = 8.8, < 0.01, χ = 15.7, < 0.01 and χ = 4.6, = 0.03) and mortality (χ = 21.1, < 0.01, χ = 25.8, < 0.01 and χ = 2.4, = 0.04) after RC while the EI showed no significant prediction. However, areas under receiver characteristic curves (AUROCs) revealed good performance only for the prediction of mortality by the aCCI and ASA (0.81 and 0.78, CGI 0.63) while the prediction of complications was poor (aCCI 0.6, ASA 0.63, CGI 0.58). The combination of ASA, age, body mass index and sex in machine learning models showed a better prediction. Gaussian naïve bayes (0.79) and logistic regression (0.76) showed the best performance using a hold-out test set.

Conclusions: The ASA and aCCI show good prediction of mortality after RC but fail predicting complications accurately. Here, the combination of comorbidity indices and clinical parameters in machine learning models seems promising.

Citing Articles

Diagnostic performance of machine-learning algorithms for sepsis prediction: An updated meta-analysis.

Zhang H, Wang C, Yang N Technol Health Care. 2024; 32(6):4291-4307.

PMID: 38968031 PMC: 11613038. DOI: 10.3233/THC-240087.

Bladder Cancer and Artificial Intelligence: Emerging Applications.

Laurie M, Zhou S, Islam M, Shkolyar E, Xing L, Liao J Urol Clin North Am. 2023; 51(1):63-75.

PMID: 37945103 PMC: 10697017. DOI: 10.1016/j.ucl.2023.07.002.

References

Uysal D, Egen L, Grilli M, Wessels F, Lenhart M, Michel M . Impact of perioperative blood transfusions on oncologic outcomes after radical cystectomy: A systematic review and meta-analysis of comparative studies. Surg Oncol. 2021; 38:101592. DOI: 10.1016/j.suronc.2021.101592. View

Froehner M, Koch R, Heberling U, Borkowetz A, Hubler M, Novotny V . Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy. Urol Int. 2020; 104(7-8):567-572. DOI: 10.1159/000507100. View

van Walraven C, Austin P, Jennings A, Quan H, Forster A . A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009; 47(6):626-33. DOI: 10.1097/MLR.0b013e31819432e5. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Golan S, Adamsky M, Johnson S, Barashi N, Smith Z, Rodriguez M . National Surgical Quality Improvement Program surgical risk calculator poorly predicts complications in patients undergoing radical cystectomy with urinary diversion. Urol Oncol. 2017; 36(2):77.e1-77.e7. DOI: 10.1016/j.urolonc.2017.09.015. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

Gagne J, Glynn R, Avorn J, Levin R, Schneeweiss S . A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011; 64(7):749-59. PMC: 3100405. DOI: 10.1016/j.jclinepi.2010.10.004. View

Taylor J, Meng X, Renson A, Smith A, Wysock J, Taneja S . Different models for prediction of radical cystectomy postoperative complications and care pathways. Ther Adv Urol. 2019; 11:1756287219875587. PMC: 6755632. DOI: 10.1177/1756287219875587. View

Dindo D, Demartines N, Clavien P . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-13. PMC: 1360123. DOI: 10.1097/01.sla.0000133083.54934.ae. View

10.

Prayer Galetti T, Soligo M, Morlacco A, Lami V, Nguyen A, Iafrate M . Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer. Aging Clin Exp Res. 2020; 33(4):1049-1061. DOI: 10.1007/s40520-020-01613-0. View

11.

Bostrom P, Kossi J, Laato M, Nurmi M . Risk factors for mortality and morbidity related to radical cystectomy. BJU Int. 2008; 103(2):191-6. DOI: 10.1111/j.1464-410X.2008.07889.x. View

12.

Gore J, Litwin M, Lai J, Yano E, Madison R, Setodji C . Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst. 2010; 102(11):802-11. PMC: 3245689. DOI: 10.1093/jnci/djq121. View

13.

Elixhauser A, Steiner C, Harris D, Coffey R . Comorbidity measures for use with administrative data. Med Care. 1998; 36(1):8-27. DOI: 10.1097/00005650-199801000-00004. View

14.

Parekh D, Reis I, Castle E, Gonzalgo M, Woods M, Svatek R . Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018; 391(10139):2525-2536. DOI: 10.1016/S0140-6736(18)30996-6. View

15.

Selvi I, Arik A, Baydilli N, Basay M, Basar H . Evaluation of comorbidity indices in determining the most suitable candidates for uro-oncological surgeries in elderly men. Cent European J Urol. 2021; 74(1):24-38. PMC: 8097655. DOI: 10.5173/ceju.2021.0246. View

16.

Kim S, Kokorovic A, Sharma V, Boorjian S, Rendon R, Bell D . Factors predicting early mortality after radical cystectomy for urothelial carcinoma in a contemporary cohort of patients. Can Urol Assoc J. 2020; 14(12):E636-E642. PMC: 7704091. DOI: 10.5489/cuaj.6400. View

17.

Williams S, Kamat A, Chamie K, Froehner M, Wirth M, Wiklund P . Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. Eur Urol Oncol. 2018; 1(2):91-100. PMC: 6190914. DOI: 10.1016/j.euo.2018.03.005. View

18.

Diamantopoulos L, Sekar R, Holt S, Khaki A, Miller N, Gadzinski A . Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy. Urol Oncol. 2021; 39(8):496.e1-496.e8. DOI: 10.1016/j.urolonc.2021.01.009. View

19.

Wessels F, Kriegmair M, Oehme A, Rassweiler-Seyfried M, Erben P, Oberneder R . Radical cystectomy under continuous antiplatelet therapy with acetylsalicylic acid. Eur J Surg Oncol. 2019; 45(7):1260-1265. DOI: 10.1016/j.ejso.2019.02.023. View

20.

Kojima G, Iliffe S, Walters K . Frailty index as a predictor of mortality: a systematic review and meta-analysis. Age Ageing. 2017; 47(2):193-200. DOI: 10.1093/ageing/afx162. View